Menu IR Home IR Home News Releases Events and Presentations Stock Information Stock Quote Interactive Stock Chart Key Ratios Analyst Coverage FAQs Financials and SEC Filings Annual Reports and Proxies Quarterly Financial Reports SEC Filings Corporate Governance Documents and Charters Management Board of Directors Committee Composition Contact the Board Contact Us News Releases Investor Alerts Year All Years 2020 2019 2018 2017 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Nov 7, 2019 Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity Nov 5, 2019 Immunic, Inc. to Participate in Industry and Investor Conferences in November Oct 15, 2019 Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson Oct 10, 2019 Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis - Milestone Achieved Nine Months Ahead of Initial Schedule; Top-Line Data Expected in Q3 2020 - Sep 30, 2019 Immunic, Inc. to Participate in Investor and Scientific Conferences in October Show 5102550100 per page«123456789»
